文献

J-GLOBAL ID：201602210081827887   整理番号：16A0127424

びまん性大細胞型B細胞リンパ腫の治療前血清中のエプスタイン-バールウイルスのDNA検出の予後診断の意義

Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma

著者 (15件)： OKAMOTO Akinao (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YANADA Masamitsu (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIURA Hiroki (Dep. of Pediatrics, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  INAGUMA Yoko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  TOKUDA Masutaka (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MORISHIMA Satoko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  KANIE Tadaharu (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YAMAMOTO Yukiya (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIZUTA Shuichi (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  AKATSUKA Yoshiki (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  YOSHIKAWA Tetsushi (Dep. of Pediatrics, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  MIZOGUCHI Yoshikazu (Dep. of Pathology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  NAKAMURA Shigeo (Dep. of Pathology and Lab. Medicine, Nagoya Univ. Hospital, Nagoya, JPN) ,  OKAMOTO Masataka (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN) ,  EMI Nobuhiko (Dep. of Hematology, Fujita Health Univ. School of Medicine, Toyoake, JPN)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 106  号： 11  ページ： 1576-1581  発行年： 2015年11月 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 治療前の血清中にエプスタイン-バールウイルス(EBV)のDN...

シソーラス用語： *B細胞リンパ腫 ,...
準シソーラス用語： EBER ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0127424&from=J-GLOBAL&jstjournalNo=U0505A") }}

分類 (2件)： 血液の腫よう  (GK04000M) ,  腫ようの診断  (GE03020J)

引用文献 (37件)：

• Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.
• Sehn LH, Donaldson J, Chhanabhai M et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027-33.
• Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121-7.
• Pfreundschuh M, Trumper L, Osterborg A et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-91.
• Pfreundschuh M, Schubert J, Ziepert M et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 2008; 9: 105-16.

タイトルに関連する用語 (6件)： びまん性大細胞型B細胞リンパ腫 ,  治療 ,  血清 ,  ウイルス ,  DNA ,  予後診断